Trials / Completed
CompletedNCT05691972
Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 225 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Contour | a sterile, biodegradable, transparent gel of nonanimal cross-linked HA (20 mg/mL) with the addition of lidocaine hydrochloride (3 mg/mL) |
Timeline
- Start date
- 2023-03-14
- Primary completion
- 2023-10-26
- Completion
- 2024-12-11
- First posted
- 2023-01-20
- Last updated
- 2025-02-17
Locations
15 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05691972. Inclusion in this directory is not an endorsement.